AHA Coding Clinic® for HCPCS - 2018 Issue 4; For Your Information

Another HCPCS code for the reporting of biosimilar products

HCPCS code Q5108, Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg, was recently added to the list of HCPCS codes utilized for the reporting of biosimilar products. This HCPCS code became effective for the reporting of services October 1, 2018. ...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

free demo
request yours today
pricing
for any budget
sign IN
welcome back!